State Requirements for Non-Medical US Cannabis Retail Personnel

被引:0
|
作者
Loparco, Cassidy R. [1 ]
Cui, Yuxian [1 ]
Mccready, Darcey [1 ]
Romm, Katelyn F. [2 ,3 ]
Yang, Y. Tony [1 ,4 ,5 ]
Rossheim, Matthew E. [6 ]
Carlini, Beatriz [7 ]
Vinson, Katie [1 ]
Cavazos-Rehg, Patricia [8 ]
Berg, Carla J. [1 ,5 ]
机构
[1] George Washington Univ, Milken Inst, Sch Publ Hlth, 950 New Hampshire Ave NW 2, Washington, DC 20052 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Norman, OK USA
[3] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK USA
[4] George Washington Univ, Sch Nursing, Washington, DC USA
[5] George Washington Univ, George Washington Canc Ctr, Washington, DC USA
[6] Univ North Texas, Hlth Sci Ctr, Sch Publ Hlth, Ft Worth, TX USA
[7] Univ Washington, Addict Drug & Alcohol Inst, Seattle, WA USA
[8] Washington Univ, Sch Med, St Louis, MO USA
关键词
budtender; cannabis; dispensary; education; policy; training;
D O I
10.1097/PHH.0000000000001892
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In September 2023, we examined requirements for budtenders working in nonmedical dispensaries in the 20 states with active non-medical cannabis markets. Two coders extracted data from each state's licensing board and/or governmental websites. The age requirement for budtenders was >= 21 years old (n = 17) or >= 18 (n = 3). Most states (n = 16) required background checks; 10 specified felony convictions preventing employment, 5 allowed the Department to determine eligibility, and 2 allowed petitions upon denial. Twelve states required fingerprinting. There were application fees ($25-$300) in 13 states. Structured training was required in 7 states, while 5 states required employee training. Given the diverse budtender requirements, the evaluation of budtender standards is essential to assess the impacts of training on regulatory compliance and consumer education, and of application costs and conviction-based employment restrictions on social equity. This must inform the development of effective regulations and enforcement protocols, as well as and how to promote equity in cannabis regulations.
引用
收藏
页码:517 / 525
页数:9
相关论文
共 50 条
  • [1] Perspectives from women who engaged in prenatal and postpartum cannabis use in a US State with legal non-medical use
    Kiel, Linda
    Hsu, Clarissa
    Wartko, Paige D.
    Albertson-Junkans, Ladia
    Ewing, John
    Lapham, Gwen T.
    PREVENTIVE MEDICINE REPORTS, 2023, 31
  • [2] Requirements for Cannabis Product Labeling by US State
    Kruger, Daniel J.
    Korach, Natalie J.
    Kruger, Jessica S.
    CANNABIS AND CANNABINOID RESEARCH, 2022, 7 (02) : 156 - 160
  • [3] Typology of Adolescents Exposed to Non-medical Cannabis Marketing and Associations with Consumption Patterns
    Pamela J. Trangenstein
    Katherine Gora Combs
    Jennifer M. Whitehill
    Marina C. Jenkins
    David H. Jernigan
    Megan A. Moreno
    Prevention Science, 2022, 23 : 1276 - 1286
  • [4] Typology of Adolescents Exposed to Non-medical Cannabis Marketing and Associations with Consumption Patterns
    Trangenstein, Pamela J.
    Combs, Katherine Gora
    Whitehill, Jennifer M.
    Jenkins, Marina C.
    Jernigan, David H.
    Moreno, Megan A.
    PREVENTION SCIENCE, 2022, 23 (07) : 1276 - 1286
  • [5] Emerging prospects for non-medical cannabis legalisation in New Zealand: An initial view and contextualization
    Fischer, Benedikt
    Bullen, Chris
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2020, 76
  • [6] Changes in online marketing and sales practices among non-medical cannabis retailers in 5 US cities, 2022 to 2023
    Cui, Yuxian
    Duan, Zongshuan
    Loparco, Cassidy R.
    Vinson, Katie
    Romm, Katelyn F.
    Wang, Yan
    Cavazos-Rehg, Patricia A.
    Kasson, Erin
    Yang, Y. Tony
    Berg, Carla J.
    PREVENTIVE MEDICINE REPORTS, 2024, 42
  • [7] Characterisation of Cannabis-Based Products Marketed for Medical and Non-Medical Use Purchased in Portugal
    Pires, Bruno
    Oliveira, Patrik
    Simao, Ana Y.
    Reis, Joao
    Ramos, Sofia
    Duarte, Ana Paula
    Margalho, Claudia
    Rosado, Tiago
    Barroso, Mario
    Gallardo, Eugenia
    MOLECULES, 2024, 29 (12):
  • [8] Access to legal cannabis market in Canada over the four years following non-medical cannabis legalisation
    Myran, Daniel Thomas
    Friesen, Erik Loewen
    Dickson, Sarah
    Konikoff, Lauren
    Arora, Gaurav
    Tanuseputro, Peter
    DRUG AND ALCOHOL REVIEW, 2023, 42 (05) : 1114 - 1119
  • [9] The adverse public health effects of non-medical cannabis legalisation in Canada and the USA
    Yimer, Tesfa Mekonen
    Hoch, Eva
    Fischer, Benedikt
    Dawson, Danielle
    Hall, Wayne
    LANCET PUBLIC HEALTH, 2025, 10 (02) : e148 - e159
  • [10] The impact of non-medical cannabis legalization and other exposures on retention in longitudinal cannabis research: a survival analysis of a prospective study of Canadian medical cannabis patients
    Philippe Lucas
    Susan Boyd
    M.-J. Milloy
    Zach Walsh
    Journal of Cannabis Research, 3